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ABSTRACT
I
n the last decade, research into the molecular
determinants of aging has progressed rapidly and much
of this progress can be attributed to studies in
invertebrate eukaryotic model organisms. Of these, single-
celled yeast is the least complicated and most amenable to
genetic and molecular manipulations. Supporting the use of
this organism for aging research, increasing evidence has
accumulated that a subset of pathways inﬂuencing longevity
in yeast are conserved in other eukaryotes, including
mammals. Here we brieﬂy outline aging in yeast and describe
recent ﬁndings that continue to keep this ‘‘simple’’ eukaryote
at the forefront of aging research.
Introduction
The budding yeast Saccharomyces cerevisiae is a widely used
model of cellular and organismal aging [1–4]. The ﬁrst studies
of yeast aging were published over 50 years ago, in which
yeast cells were shown to have a ﬁnite replicative capacity [5].
Replicative life span was thus deﬁned as the number of
daughter cells produced by a mother cell before senescence.
A second model of aging has more recently been developed in
yeast, termed chronological aging. In contrast to replicative
life span (RLS), chronological life span (CLS) is deﬁned as the
length of time a yeast cell can survive in a nondividing state
[6]. These two models for aging in yeast (Figure 1) provide a
unique opportunity to compare and contrast the aging
processes of both proliferating and nonproliferating cells in a
simple single-celled organism [3].
An interesting parallel has emerged from studies in both
yeast aging models linking environmental nutrients to
longevity. In the lab, yeast cells are typically grown in media
containing high levels of glucose (2%) and abundant amino
acids. Independent studies have determined that reducing
either the glucose or amino acid concentrations of the media
(or both) can increase replicative and chronological life span
[7–12]. These different nutrient restriction paradigms have all
been referred to as calorie restriction. Calorie restriction is
known to increase life span in a variety of organisms other
than yeast, including worms, ﬂies, and rodents [13,14]. Given
that there is some debate about whether the life-span beneﬁts
of these interventions are a direct result of reduced caloric
input [15–17], we have chosen to use term dietary restriction
(DR) hereafter. There is much interest in determining whether
the mechanism(s) by which DR increases longevity in yeast are
evolutionarily conserved. A major focus of yeast aging
research recently has been directed at understanding the
mechanisms that underlie life span extension by DR in yeast.
Dietary Restriction and Sir2: Still Looking for
Consensus
Much of the popular interest in yeast aging over the past
several years has developed from studies of the silent
information regulator 2 (Sir2) family of protein deacetylases
(sirtuins). A role for sirtuins in longevity determination was
ﬁrst suggested from work showing that deletion of SIR2
shortens replicative life span [18], while overexpression
increases replicative life span [19]. Sir2 orthologs have since
been reported to play a similar role in determining the
longevity of both worms and ﬂies [20, 21].
In yeast, both overexpression of SIR2 and deletion of FOB1
repress homologous recombination at rDNA repeats.
Recombination of rDNA results in the accumulation of
extrachromosomal rDNA circles, which can lead to
replicative senescence [22]. While it was initially proposed
that DR increases RLS in yeast by activating the Sir2 enzyme
[11], this model has been challenged by a series of recent
studies demonstrating that DR can increase RLS by a SIR2-
independent mechanism [23–25]. Although DR fails to
increase RLS in a sir2D mutant, DR robustly increases the RLS
of sir2D fob1D double mutant cells, demonstrating that Sir2 is
not required for life span extension by DR [24]. It remains
controversial whether the Sir2 ortholog Hst2 could mediate
RLS extension by DR in yeast under speciﬁc DR conditions
when Sir2 is absent [26,27]; however, recent ﬁndings indicate
that DR can increase RLS through a mechanism that is
independent of all yeast sirtuins [28]. Arguments regarding
the relevance of Sir2 in DR have been covered in greater
detail in recent reviews and commentaries, and we refer the
interested reader to these sources [29–31].
In the chronological aging paradigm Sir2 does not promote
longevity and appears to play an antagonistic role in the
response to DR [8]. Unlike RLS, deletion of SIR2 does not
shorten CLS under normal growth conditions [8]. When cells
are subjected to DR, deletion of Sir2 signiﬁcantly increases
CLS [8]. One mechanism that has been proposed for this
antilongevity function of Sir2 involves regulating the
expression of alcohol dehydrogenase, which is important for
metabolism of ethanol late in stationary phase [8]. Whether
additional functions of Sir2 are involved as well, such as its
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mother and daughter cells [32], remains to be determined.
Apoptosis and Oxidative Stress: Cause or Effect?
An interesting question that has emerged from recent
studies is the potential relationship between an apoptosis-like
pathway and cellular senescence in yeast. Morphological and
molecular features resembling apoptosis in metazoan cells
were initially reported in a S. cerevisiae strain with a point
mutation in the CDC48 gene [33]. Since this original
characterization, apoptotic phenotypes in yeast have been
reported to occur under a variety of conditions, including
overexpression of pro-apoptotic mammalian BAX [34], by
transfer of a stationary culture to a glucose medium lacking
additional nutrients to support growth [35], and by treatment
with low concentrations of H2O2 [36].
Of particular interest to the ﬁeld of aging is the effect of
oxidative stress on aging cells. Reactive oxygen species
accumulate during the diauxic shift and stationary phase, as
cells switch from fermentation to oxidative phosphorylation
[37]. Reactive oxygen species are also potent stimulators of
the mitochondrial cell death pathway, causing loss of
mitochondrial membrane potential and export of
cytochrome C. Interestingly, either deletion in the yeast
ortholog of the apoptosis-inducing factor AIF1 [38] or
overexpression of anti-apoptotic mammalian BCL2 [39]
rescues the apoptotic phenotype induced by ROS.
With regard to these recent advances, the link between
yeast apoptosis and aging remains correlative, but highly
intriguing. Both replicatively and chronologically aged cells
show markers consistent with apoptotic death [37]. At
present, however, it remains unclear whether there exists a
causal relationship between apoptosis and senescence in
yeast. It has been reported that deletion of the yeast caspase
YCA1 results in an increase in chronological longevity, but
only after the culture falls below 10% viability [40]. This
suggests that apoptosis exerts an effect on longevity only after
the majority of cells have already undergone senescence.
Thus, for most cells in the population, activation of the
apoptosis-like pathway may be a response to the damage
leading to senescence. The observation that apoptotic
markers are present in both replicative and chronologically
senescent cells may be an indication that the ultimate cause
of senescence is similar in both dividing and nondividing
yeast cells. This would be consistent with the ﬁnding that
chronologically aged cells have a reduced RLS [41] and that
some interventions (e.g., DR or reduced target-of-rapamycin
(TOR) signaling) increase both RLS and CLS (see below).
It has also been suggested that apoptosis-like events in
chronologically aged cells provide an opportunity for a few
individual cells within the population to resume cell division.
This argument is based on observations that, at a low
frequency, vegetative growth will occasionally be observed
late in stationary-phase cultures [42]. It has recently been
speculated that this ‘‘gasping’’ effect is an altruistic
phenomenon, whereby the majority of cells in an aging
population die through a process resembling apoptosis in
order to facilitate the outgrowth of a few remaining viable
cells [42]. This hypothesis, although controversial, provides an
interesting link between replicative and chronological
longevity and also suggests a potential mechanism for how an
apoptosis-like pathway might evolve in a single-celled
eukaryote.
Genome-Wide Screens Elaborate the Importance of
Nutrient-Responsive Kinases
An important advance in the ﬁeld of yeast aging over the
last two years has been the development and application of
genomic methods for assaying longevity [12,25]. Previously,
studies of aging in yeast had been limited to a relatively small
number of genes and relied on biased approaches: testing of
candidate genes based on prior knowledge or assumptions
and screening for secondary phenotypes, such as stress
resistance [18,43] or age-associated changes in gene
expression that may correlate with longevity [44].
Two reports from genome-wide studies of yeast aging,
carried out using a collection of ;4,900 isogenic single-gene
deletion strains [45], have identiﬁed the nutrient-responsive
TOR signaling pathway as an important mediator of both
replicative and chronological life span [12,25]. Mutations that
decrease TOR activity were found to increase the longevity of
both dividing and nondividing yeast cells [12,25].
Interestingly, decreased TOR activity also increases life span
in both worms and ﬂies [46–48], suggesting an evolutionarily
conserved role for TOR as a conduit linking nutrient status to
longevity.
In yeast, TOR acts in concert with other nutrient-
responsive kinases, Sch9 and protein kinase A (PKA), to
coordinate the cellular response to altered glucose and
nitrogen levels [49,50]. Prior studies had implicated roles for
both Sch9 and PKA in yeast aging. Similar to inhibition of
TOR, deletion of Sch9 increases both replicative and
chronological life span [25,43,51]. Likewise, a temperature-
sensitive allele of yeast adenylate cyclase (cyr1–1) that
decreases PKA activity increases both replicative and
chronological life span [9,43]. Suprisingly, deletion of small G
proteins that activate the PKA pathway, Ras1 and Ras2,
doi:10.1371/journal.pgen.0030084.g001
Figure 1. Schematic for Yeast Replicative and Chronological Aging
(A) RLS in yeast is measured by the number of mitotic divisions that can
arise from a single mother cell. Replicative viability is calculated as the
mean number of daughters produced from mothers of a particular strain
background before senescence.
(B) CLS is measured by the length of time cells in a stationary culture can
remain viable. Viability is calculated by the fraction of the culture able to
reenter the cell cycle after an extended state of quiescence.
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replicative life spans; deletion of RAS1 increases RLS while
slightly decreasing CLS, while deletion of RAS2 decreases
RLS, but dramatically extends CLS [9,51,52]. Thus, multiple
studies have independently uncovered an important role for
these nutrient-responsive signaling pathways in determining
yeast longevity.
How might decreased activity of nutrient-responsive
kinases lead to increased life span? TOR, Sch9, and PKA play
overlapping regulatory roles in several cellular processes that
could be of relevance for longevity (Figure 2). In the
remainder of this review, we consider which downstream
functions are most likely to determine longevity in yeast and,
potentially, other organisms.
Stress response. One function of TOR, Sch9, and PKA is to
repress a general stress response by regulating localization of
the transcription factors Msn2 and Msn4 [53–56]. Under
conditions of high nutrient availability Msn2/4 are retained in
the cytoplasm, where they are unable to activate transcription
of starvation-induced stress proteins [53]. Under starvation
conditions, or upon treatment with the TOR-inhibitor
rapamycin, Msn2/4 relocalize to the nucleus, resulting in
enhanced resistance to oxidative and temperature stress.
Extension of CLS by the RAS2 deletion appears to be due in
part to Msn2/4 activation [9]; however, the chronological life
span extension imparted by deletion of Sch9 is independent
of Msn2/4; instead, it partly involves activation of RIM15 [43],
which mediates entry into stationary phase and activation of
stress-responsive genes under those conditions [57].
Although it has not been demonstrated that activation of
Msn2/4 is sufﬁcient to either increase replicative or
chronological life span, there is indirect evidence supporting
the idea that Msn2/4 are involved in chronological life span
extension from TOR inhibition. For instance, overexpression
of the Msn2/4 target genes SOD1 and SOD2 is sufﬁcient to
increase chronological life span [9], suggesting that decreased
TOR activity results in increased chronological life span, at
least partially, through upregulation of superoxide dismutase
activity. Thus, one mechanism by which decreased nutrient
availability might slow chronological aging is through an
upregulation of stress resistance via activation of Msn2/4 and
other pathways.
Interestingly, replicative life span extension from SCH9
deletion, mutations reducing PKA activity, or DR is not
dependent on Msn2/4 [11,58]. Thus, given the current
available data, the Msn2/4-mediated stress response appears
to play an important role in nutrient-mediated
chronological, but perhaps not replicative, life-span
extension in yeast.
Retrograde response. The retrograde response has been
deﬁned as a mitochondrion-to-nucleus signaling pathway
that is activated in response to mitochondrial dysfunction
[59,60]. This process is mediated by the transcription factors
Rtg1 and Rtg3, which coordinate expression of enzymes
involved in anapleurotic production of a-ketoglutarate. The
retrograde response has been previously implicated in yeast
replicative longevity, with the observation that deletion of
mitochondrial DNA (rho
0) can increase life span in a
retrograde-dependent manner [61]. The relevance of this
ﬁnding has been difﬁcult to determine, however, because
deletion of mitochondrial DNA increases replicative life span
in only one out of the six yeast strains in which it has been
studied [23,52,61].
In addition to mitochondrial dysfunction, however,
retrograde gene expression is also regulated by TOR activity,
and treatment of cells with rapamycin induces Rtg1/3-target
genes [62,63]. Thus, it is reasonable to speculate that one
mechanism by which TOR inhibition could inﬂuence
replicative longevity is by altering retrograde gene
expression. It will be of interest to determine whether Rtg1
and Rtg3 are required for replicative or chronological life
span extension from TOR inhibition. Interestingly, deletion
of the retrograde target gene IDH2, coding for isocitrate
dehydrogenase, also increases yeast replicative life span [25]
and two different isocitrate dehydrogenase enzymes are
reported to similarly affect longevity in C. elegans [64]. Thus,
there is evidence that altering the expression of TOR-
regulated retrograde target genes can inﬂuence longevity.
Autophagy. Yet another important function of TOR
proteins is to repress autophagy [65,66]. Autophagy is a
starvation response in which cellular macromolecules are
recycled through vesicular transport and degradation in
lysosomal or vacuolar compartments [67]. Autophagy has
been implicated in age-associated disease, and autophagy
decreases as a function of age in rodents [68–71] More
recently, it was shown that increased autophagy is required
for full life-span extension in C. elegans in a long-lived daf-2
mutant [72].
Although direct experimental data is lacking, autophagy
could be an important mediator of yeast longevity,
particularly chronological life span. It is known that yeast
cells upregulate autophagy during entry into stationary
phase, presumably as an adaptive response to starvation [66].
Consistent with this, several mutants defective for autophagy
are short-lived in the chronological aging assay [12].
doi:10.1371/journal.pgen.0030084.g002
Figure 2. TOR Kinase Mediates Important Cellular Responses Implicated
in Extended Longevity
During periods of nutrient availability, TOR kinase is activated, leading to
G1 progression, translation initiation, increased ribosome biogenesis,
and a suppression of autophagy and the stress response.
When TOR is inactivated, either by DR or by the TOR inhibitor rapamycin,
a cellular response is initiated that turns down protein translation and
cell growth, and increases protein turnover and genes involved in the
stress response. The conserved cellular regime that is the result of
inactivated TOR kinase increases both replicative and chronological life
span in yeast.
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nitrogen starvation induces autophagy [66] and also increases
chronological life span [12]. Enhanced autophagy could have
several beneﬁcial properties in aging post-mitotic cells,
including degradation of oxidatively damaged proteins,
inhibition of protein aggregation, and recycling of damaged
mitochondria. It will therefore be of interest to determine
whether increased autophagy is important for life-span
extension from DR or TOR inhibition in either or both of the
yeast aging models.
Changes in carbon metabolism. Yeast cells have evolved to
undergo a variety of metabolic changes in response to
ﬂuctuating nutrient levels in the environment, many of which
are coordinated by TOR, Sch9, and PKA. In particular, yeast
respond robustly to decreasing glucose levels by shifting their
metabolic state from one that favors fermentation to one that
favors respiration. It has been proposed that this shift in
carbon metabolism may account for the increase in RLS
observed in response to DR [73]. The mechanism postulated
by this model was that enhanced respiratory activity would
activate Sir2, thus increasing life span. Contrary to this
hypothesis, DR increases the RLS of respiratory-deﬁcient
cells [23]. This is true, even in cells completely lacking
mitochondrial DNA. Similar to the case with SIR2 and DR,
there continues to be disagreement about the requirement of
respiration for life-span extension by DR, and it has been
recently reported that deletion of LAT1, which encodes a
component of the mitochondrial pyruvate dehydrogenase
complex, also is required for life span extension by DR [74].
There is additional evidence that changes associated with
respiratory metabolism can inﬂuence both RLS and CLS. For
example, overexpression of the glucose-repressible gene
HAP4 is sufﬁcient to increase both RLS [73] and CLS [4], even
when glucose levels are high. Hap4 is a regulatory subunit
required for optimal transcriptional activation by the Hap2/3/
5 complex, which induces respiratory genes in response to the
available carbon source. Putative Hap2/3/5 binding domains
have also been identiﬁed in the TSA2 (thiol-speciﬁc
antioxidant) promoter, which responds to increased
oxidative and nitrosative stress [75]. In that report,
overexpression of HAP4 was demonstrated to induce TSA2
expression. Thus, in addition to inducing respiration, HAP4 is
important for promoting cellular stress resistance. It remains
to be determined whether the effects of HAP4 overexpression
on replicative and chronological longevity are related to its
effects on respiratory metabolism or a different function.
Decreased ribosome biogenesis and translation. One of the
primary functions of TOR, Sch9, and PKA is to modulate
protein translation in response to environmental cues
[49,76,77]. In yeast, one mechanism by which these kinases
regulate translation is by promoting transcription of
ribosomal proteins (RPs) and rRNA processing factors. Under
conditions of glucose or nitrogen starvation, or upon
inhibition of TOR with rapamycin, RP transcription is
dramatically reduced and translation in general is impaired
[49,63,76,77].
A link between TOR, RPs, and longevity was suggested from
the initial results of a genome-wide screen for replicatively
long-lived mutants. Replicative life span was determined for
564 single-gene deletion strains randomly chosen from the
yeast ORF deletion collection, resulting in the identiﬁcation
of 13 long-lived mutants [25]. In addition to TOR1, the
deleted genes from these 13 long-lived strains included two
TOR-regulated RP genes, RPL31A and RPL6B. We have since
determined that several other RP and rRNA processing factor
deletion mutants are also long-lived (our unpublished data),
and Chiocetti et al. [78] recently reported that RPS6B and
RPL10 similarly regulate replicative longevity. These ﬁndings
suggest the possibility that one mechanism by which
decreased TOR activity can increase replicative life span is by
decreasing ribosome function and translation. In this regard,
it is noteworthy that mutations in S6 kinase, a downstream
target of TOR involved in ribosome maturation, have been
reported to increase life span in ﬂies [47], and several recent
reports have implicated mRNA translation as a critical
determinant of longevity in worms [79–81].
From Yeast to Mammals
It remains an open question how much of the aging process
will be conserved from yeast into higher organisms. Clearly,
some aspects of aging in yeast are speciﬁc to yeast. Others,
however, appear to be highly conserved. Life span extension
from Sir2-overexpression, TOR-inhibition, Sch9/Akt or DR,
for example, has been observed in yeast, worms, and ﬂies. It is
likely that several additional conserved longevity factors will
be identiﬁed from ongoing genome-wide screens in yeast and
worms [12,25,52,64,82–85] and studies in mammalian models.
If a given gene functions similarly to regulate longevity in
yeast, worms, and mice, there is a good chance this function
will be conserved in humans. In this way, yeast may serve as a
foundation for identifying potential targets for intervening in
human longevity and age-associated disease.
The observation that TOR, Sch9/Akt, and PKA could be
regulating longevity differently in replicative and
chronologically aging yeast cells is noteworthy, given that DR
appears to retard a variety of age-associated diseases in
tissues of higher animals [14]. The beneﬁcial effects of
reduced nutrient signaling may be dependent on the
proliferative state of the tissue in question in mammals. Mice
subjected to DR are resistant to carcinogenesis and display
reduced age-associated pathologies in brain, liver, heart,
muscle, and other tissues. How is it that DR has such a broad
spectrum of beneﬁcial effects in complex organisms? Based
on the studies in yeast described above, we speculate that a
few key nutrient-responsive proteins (such as TOR) may serve
as evolutionarily conserved gatekeepers to synthesize inputs
from the environment into appropriate tissue-speciﬁc
outputs. For example, in neuronal cells, enhanced
degradation of aggregated proteins through increased
autophagy might be of particular relevance, whereas in
ﬁbroblasts increased resistance to stress or appropriate
modulation of ribosome function could be most important.
Future studies of the differential responses of different cell
types to DR and TOR inhibition will be important for testing
this idea.
A growing body of evidence clearly suggests that aging is
determined, at least in part, by ancestral evolutionary origins.
Due to this conservation, yeast remains a powerful tool for
dissecting the genetic and biochemical factors that modulate
longevity. As large-scale screens for long-lived yeast deletion
mutants draw closer to completion, new and unexpected
pathways are being uncovered, bringing a global picture of
cellular aging into sharper focus. The knowledge gained from
the molecular biology of aging in yeast yields a foundation on
PLoS Genetics | www.plosgenetics.org May 2007 | Volume 3 | Issue 5 | e84 0658which to approach the puzzle of multicellular aging in tissues
and in higher organisms. “
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